Cargando…
Statins: Could an old friend help in the fight against COVID‐19?
The COVID‐19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has overwhelmed healthcare systems requiring the rapid development of treatments, at least, to reduce COVID‐19 severity. Drug repurposing offers a fast track. Here, we discuss the potential beneficial ef...
Autores principales: | Rodrigues‐Diez, Raul R., Tejera‐Muñoz, Antonio, Marquez‐Exposito, Laura, Rayego‐Mateos, Sandra, Santos Sanchez, Laura, Marchant, Vanessa, Tejedor Santamaria, Lucía, Ramos, Adrian M., Ortiz, Alberto, Egido, Jesus, Ruiz‐Ortega, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323198/ https://www.ncbi.nlm.nih.gov/pubmed/32562276 http://dx.doi.org/10.1111/bph.15166 |
Ejemplares similares
-
Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
por: Lavoz, Carolina, et al.
Publicado: (2020) -
Role of Macrophages and Related Cytokines in Kidney Disease
por: Cantero-Navarro, Elena, et al.
Publicado: (2021) -
CCN2 Binds to Tubular Epithelial Cells in the Kidney
por: Rayego-Mateos, Sandra, et al.
Publicado: (2022) -
IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis
por: Marchant, Vanessa, et al.
Publicado: (2020) -
CCN2 Increases TGF-β Receptor Type II Expression in Vascular Smooth Muscle Cells: Essential Role of CCN2 in the TGF-β Pathway Regulation
por: Tejera-Muñoz, Antonio, et al.
Publicado: (2021)